IGF1 and colorectal carcinoma: However, studies that demonstrated that increased IGF-1 levels were associated with an increased risk of CRC were performed prior to the diagnosis of CRC, whereas those that revealed lower levels in patients compared to those in controls were performed in patients with advanced disease, after the beginning of treatment and disease progression.